by McKesson Ventures | Apr 14, 2023 | Press Releases
Bioinformatics company M2GEN has announced that it is rebranding, changing its name to Aster Insights. As the nexus between patients, researchers, and the life sciences industry, the company’s unique clinical and molecular dataset has enabled new insights for...
by McKesson Ventures | Jan 18, 2022 | Press Releases
Bioinformatics company M2GEN is known for its constant push to further oncology research discoveries through analytics and data. It recently announced an expansion of its executive team, appointing two new members: May Yoon has joined as chief people officer and...
by McKesson Ventures | Dec 9, 2021 | Press Releases
Bioinformatics company M2GEN announced a partnership with Microsoft in a move to improve and expand its data-driven solutions for research, discovery, and development of oncology therapies. The collaboration will combine M2GEN’s clinico-genomics database with...
by McKesson Ventures | Aug 2, 2021 | Press Releases
M2GEN, a company focused on transforming cancer care through data and informatics, has announced the appointment of Jim Gabriele as president and chief executive officer. Gabriele is a seasoned entrepreneur and data science leader who most recently served as senior...
by McKesson Ventures | Mar 17, 2021 | Press Releases
Oncology data and informatics platform M2GEN has announced a significant investment by three major venture investment firms: Clayton, Dubilier & Rice (CD&R), Merck Global Health Innovation Fund (Merck GHI), and McKesson Ventures. The investment will...
